Watch replays of the main stage programming from the SOSV Climate Tech Summit (Nov. 5-6)

Making Every Breath Count

Team

Nick Delmonico

Co-Founder

Richard Powers

Founder

Strados Labs

Company details

Strados offers a COPD feedback monitoring system that provides automatic reports to doctors on unusual lung activity in patients. The company’s RESP product allows one respiratory professional to remotely monitor the conditions of at least 10x the number of patients than otherwise possible, providing continuous lung monitoring to determine which patients are getting worse and when. The system enables enhanced patient monitoring for overloaded hospitals, while also reducing patient and health care provider contact and exposure risk to COVID-19. The product is available now for research and on a compassionate use basis, with clinical trials at leading hospitals ongoing. Read more about it in the Philadelphia Business Journal and in metagadget.

Get In Touch with Strados Labs

Please tell us a little bit about yourself and why you'd like to get connected. Strados Labs + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More